Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xtacy Therapeutics (DE:TT5)
FRANKFURT:TT5
RESEARCH TOOLSreports
Xtacy Therapeutics (TT5) Financial Statements
0 Followers
Xtacy Therapeutics Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | C$ -359.74K | C$ -261.63K | C$ -150.12K | C$ -487.24K | C$ -747.72K |
| EBITDA | C$ -359.74K | C$ -261.63K | C$ -150.12K | C$ -487.24K | C$ -747.72K |
| Net Income Common Stockholders | C$ -362.52K | C$ -264.13K | C$ -152.60K | C$ -490.41K | C$ -748.12K |
| Balance Sheet | - | ||||
| Cash Cash Equivalents And Short Term Investments | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 16.07K |
| Total Assets | C$ 75.02K | C$ 149.47K | C$ 223.71K | C$ 297.83K | C$ 16.07K |
| Total Debt | C$ 15.97K | C$ 15.97K | C$ 11.37K | C$ 25.37K | C$ 24.99K |
| Net Debt | C$ 15.97K | C$ 15.97K | C$ 11.37K | C$ 25.37K | C$ 8.93K |
| Total Liabilities | C$ 645.49K | C$ 773.86K | C$ 788.96K | C$ 746.49K | C$ 616.41K |
| Stockholders Equity | C$ -570.47K | C$ -624.38K | C$ -565.25K | C$ -448.66K | C$ -600.34K |
| Cash Flow | - | ||||
| Free Cash Flow | C$ 104.60K | C$ -4.60K | C$ 36.00K | C$ -2.89K | C$ -309.74K |
| Operating Cash Flow | C$ 104.60K | C$ -4.60K | C$ 36.00K | C$ -2.89K | C$ -309.74K |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | C$ -104.60K | C$ 4.60K | C$ -36.00K | C$ 228.67K | C$ 24.99K |
Xtacy Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.